XML 38 R2.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Total revenues $ 3,616.7 $ 3,356.5 $ 7,106.5 $ 6,487.6
Cost and expenses:        
Cost of sales, excluding amortization and impairment of acquired intangible assets 476.3 421.0 1,078.3 867.0
Research and development 484.8 981.0 1,048.5 1,477.7
Selling, general and administrative 587.6 516.2 1,155.3 1,017.5
Amortization and impairment of acquired intangible assets 70.1 107.4 138.3 211.3
Collaboration profit (loss) sharing 63.5 39.2 121.6 81.7
Loss on assets and liabilities held for sale (2.3) 0.0 113.2 0.0
(Gain) loss on fair value remeasurement of contingent consideration (20.0) 1.9 (8.5) (3.7)
Restructuring charges 0.8 1.6 1.2 3.2
Acquired in-process research and development 0.0 75.0 0.0 85.0
Total cost and expenses 1,660.8 2,143.3 3,647.9 3,739.7
Income from operations 1,955.9 1,213.2 3,458.6 2,747.9
Other income (expense), net (197.4) (34.5) 159.9 (75.5)
Income before income tax expense and equity in loss of investee, net of tax 1,758.5 1,178.7 3,618.5 2,672.4
Income tax expense 248.1 263.7 670.6 586.2
Equity in loss of investee, net of tax 16.3 0.0 45.0 0.0
Net income 1,494.1 915.0 2,902.9 2,086.2
Net income (loss) attributable to noncontrolling interests, net of tax 0.0 48.4 0.0 46.7
Net income attributable to Biogen Inc. $ 1,494.1 $ 866.6 $ 2,902.9 $ 2,039.5
Net income per share:        
Basic earnings per share attributable to Biogen Inc. $ 7.85 $ 4.18 $ 15.01 $ 9.75
Diluted earnings per share attributable to Biogen Inc. $ 7.85 $ 4.18 $ 14.99 $ 9.73
Weighted-average shares used in calculating:        
Basic earnings per share attributable to Biogen Inc. 190.3 207.1 193.4 209.2
Diluted earnings per share attributable to Biogen Inc. 190.4 207.3 193.7 209.5
Product, net        
Total revenues $ 2,880.3 $ 2,757.5 $ 5,560.3 $ 5,281.0
Revenues from anti-CD20 therapeutic programs        
Total revenues 576.4 490.4 1,093.8 933.6
Other        
Total revenues $ 160.0 $ 108.6 $ 452.4 $ 273.0